KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Neogenomics (NEO) over the last 17 years, with Sep 2025 value amounting to $765,000.

  • Neogenomics' Cash from Financing Activities fell 35.00% to $765,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$200.0 million, marking a year-over-year decrease of 3925.44%. This contributed to the annual value of $4.6 million for FY2024, which is 2.02% up from last year.
  • Neogenomics' Cash from Financing Activities amounted to $765,000 in Q3 2025, which was up 100.38% from -$202.4 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Cash from Financing Activities registered a high of $524.9 million during Q1 2021, and its lowest value of -$202.4 million during Q2 2025.
  • For the 3-year period, Neogenomics' Cash from Financing Activities averaged around -$17.4 million, with its median value being $949,000 (2025).
  • As far as peak fluctuations go, Neogenomics' Cash from Financing Activities skyrocketed by 84,978.61% in 2021, and later crashed by 10,396.69% in 2025.
  • Over the past 5 years, Neogenomics' Cash from Financing Activities (Quarterly) stood at $2.5 million in 2021, then dropped by 26.75% to $1.8 million in 2022, then fell by 29.52% to $1.3 million in 2023, then tumbled by 45.91% to $687,000 in 2024, then crashed by 35.00% to $765,000 in 2025.
  • Its last three reported values are $765,000 in Q3 2025, -$202.4 million for Q2 2025, and $949,000 during Q1 2025.